Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategy
Abstract Colistin remains one of the last-resort therapies for combating infections caused by multidrug-resistant (MDR) Enterobacterales, despite its adverse nephro- and neuro-toxic effects. This study